Mark Heise

4PUBLICATIONS
15CO-AUTHORS
Cardiology (incl. cardiovascular diseases)Respiratory diseasesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Immunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Mar 11, 2026
Effect of Clazakizumab on Neutrophil-Lymphocyte Ratio in Patients Receiving Hemodialysis: Secondary Analysis of the POSIBIL6ESKD Phase 2b Trial.

Benjamin Catanese, Mark Heise, Anna M Chang

|Feb 05, 2025
Effects of Clazakizumab on Anemia and Iron Metabolism in Patients with Kidney Failure.

Brendon L Neuen, Benjamin Catanese, Annamarie Chang

|Jul 03, 2024
Author Correction: IL-6 inhibition with clazakizumab in patients receiving maintenance dialysis: a randomized phase 2b trial.

Glenn M Chertow, Anna Marie Chang, G Michael Felker

|May 25, 2024
IL-6 inhibition with clazakizumab in patients receiving maintenance dialysis: a randomized phase 2b trial.

Glenn M Chertow, Anna Marie Chang, G Michael Felker

Pageof 1

Frequent Collaborators

4 joint publications

Glenn M Chertow

4 joint publications

Myles Wolf

2 joint publications

C Michael Gibson

2 joint publications

Adeera Levin